MrStefan Boncel CEOModerna Major drug manufacturersunited states said on Monday (17 Jan. 65) that the vaccine against COVID-19 Omicron speciesIt will enter clinical trials in the coming weeks.
“This vaccine is being finished. which should be inclinical trial procedureIn a few weeks, we hope that in March the information can be shared with regulators. to find the next step,” Bongzel said at the World Conference. Virtual Economy Forum
In addition, Moderna also developedsingle dose vaccine which includes anti-stimulation needleCovid-19 withflu vaccinebig
Boncel said the best scenerio is to haveCovid-Influenza VaccineMixed will be available in at least some countries. By the fall of 2023
At present, many countries have startedcovid vaccinationThe third pin was given to their own people. starting from the risk group and those with impaired immune systems, whileIsraelThe fourth injection has begun.
In early January, the Moderna CEO said people had toFourth injectionIn the summer of 2022, as the efficacy of the booster spike is likely to decline over the next few months.
However, givingbooster vaccinefaced skepticism from some disease experts, includingEuropean Medicines Agency which expressed doubts about the need for a fourth dose of vaccination.
Proofread by….Suree Silawong
.
